KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacific Biosciences Of California (PACB) Interest Expenses (2016 - 2025)

Pacific Biosciences Of California (PACB) has 14 years of Interest Expenses data on record, last reported at $1.7 million in Q4 2025.

  • For Q4 2025, Interest Expenses fell 36.89% year-over-year to $1.7 million; the TTM value through Dec 2025 reached $7.0 million, down 48.15%, while the annual FY2025 figure was $7.0 million, 48.15% down from the prior year.
  • Interest Expenses reached $1.7 million in Q4 2025 per PACB's latest filing, roughly flat from $1.7 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $3.7 million in Q1 2022 and bottomed at $1.7 million in Q1 2025.
  • Average Interest Expenses over 5 years is $3.1 million, with a median of $3.6 million recorded in 2023.
  • Peak YoY movement for Interest Expenses: skyrocketed 570.04% in 2021, then crashed 51.41% in 2025.
  • A 5-year view of Interest Expenses shows it stood at $3.5 million in 2021, then grew by 4.86% to $3.6 million in 2022, then dropped by 2.11% to $3.6 million in 2023, then dropped by 22.79% to $2.8 million in 2024, then tumbled by 36.89% to $1.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Interest Expenses were $1.7 million in Q4 2025, $1.7 million in Q3 2025, and $1.7 million in Q2 2025.